Navigation Links
Surpass Superfusion

ProductsSurpass Superfusion
Company Boston Scientific Corporation
Item Surpass Superfusion
Features 
  • Continued Flow and Guidewire Security - allows continued blood flow with no guidewire pull back. Average flow rate, 45cc/min. Separate guidewire and blood flow lumens maintain distal wire position with continuous perfusion.*
  • Low Profile LEAP Balloon Material - provides excellent versatility. The low-profile, high pressure balloon material you need for today's interventional cases.
  • .018" Swift Tip Design - shortest tip configuration of any perfusion catheter. Optimal performance for reaching distal lesions. LEAP balloon material and Swift Tip combine to improve crossability.
  • Collapse-Resistant Hemocoil Perfusion Lumen - advanced structural support is strong, yet flexible, with a reduced profile. Outstanding performance in tortuous vessels and lesions on a bend.
  • Unique Design - single port design. Independent blood flow and guidewire lumens.
  • Description The SURPASS Perfusion Catheter is indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion. The SURPASS Perfusion Catheters are also designed to provide distal blood perfusion during balloon inflations.
    Info Boston Scientific Corporation
    Customer Service: (888) 272-1001
    Web site: http://www.bostonscientific.com

    Related medicine products :

    1. Surpass Superfusion Long
    Biocryl™ Acrylic Foldable Lens....
    The STAAR ELASTIMIDE lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
    ... Lomb UV-Absorbing, Silicone Posterior Chamber Intraocular Lens ... for the visual correction of aphakia in ... in whom the cataractous lens has been ... device is intended to be placed only ...
    ... lenses are manufactured using the ... Perspex CQ UV PMMA material ... and single piece lenses. Unioptic ... both nonphaco and phaco styles. ...
    Medicine Products:
    (Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
    (Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
    (Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
    (Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
    (Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
    Breaking Medicine News(10 mins):
    (Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
    (Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
    (Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
    Breaking Medicine Technology: